Tabula Rasa HealthCare Inc (NASDAQ:TRHC) has earned an average recommendation of “Buy” from the twelve analysts that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $28.75.

TRHC has been the subject of several recent research reports. First Analysis initiated coverage on Tabula Rasa HealthCare in a report on Wednesday, November 1st. They set an “overweight” rating and a $41.00 price target for the company. Piper Jaffray Companies reaffirmed an “overweight” rating and issued a $35.00 price objective on shares of Tabula Rasa HealthCare in a research note on Tuesday, November 7th. They noted that the move was a valuation call. Zacks Investment Research raised Tabula Rasa HealthCare from a “hold” rating to a “strong-buy” rating and set a $31.00 price objective for the company in a research note on Wednesday, October 11th. Wells Fargo & Co upped their price objective on Tabula Rasa HealthCare from $21.00 to $27.00 and gave the stock a “market perform” rating in a research note on Thursday, October 19th. Finally, William Blair started coverage on Tabula Rasa HealthCare in a research note on Monday, December 11th. They issued an “outperform” rating for the company.

Tabula Rasa HealthCare (TRHC) traded down $0.49 during trading hours on Monday, reaching $28.05. The company’s stock had a trading volume of 143,200 shares, compared to its average volume of 109,805. Tabula Rasa HealthCare has a twelve month low of $11.59 and a twelve month high of $36.80. The company has a quick ratio of 0.66, a current ratio of 0.73 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $500.66, a price-to-earnings ratio of -112.20, a PEG ratio of 37.40 and a beta of 3.20.

Tabula Rasa HealthCare (NASDAQ:TRHC) last released its quarterly earnings results on Monday, November 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.06 by $0.02. Tabula Rasa HealthCare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The business had revenue of $33.27 million during the quarter, compared to analyst estimates of $31.76 million. During the same quarter in the previous year, the company posted $0.06 earnings per share. Tabula Rasa HealthCare’s revenue for the quarter was up 37.6% on a year-over-year basis. equities analysts anticipate that Tabula Rasa HealthCare will post 0.03 earnings per share for the current year.

In related news, Director Bruce Luehrs sold 269,000 shares of the business’s stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $25.85, for a total value of $6,953,650.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, major shareholder Growth Fund 1Q Lp Originate sold 684,180 shares of the business’s stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $25.85, for a total value of $17,686,053.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,099,180 shares of company stock valued at $28,435,203. Corporate insiders own 45.80% of the company’s stock.

Several large investors have recently bought and sold shares of the stock. Paradigm Capital Management Inc. NY lifted its position in shares of Tabula Rasa HealthCare by 3.4% in the third quarter. Paradigm Capital Management Inc. NY now owns 80,000 shares of the company’s stock worth $2,139,000 after buying an additional 2,644 shares in the last quarter. Wells Fargo & Company MN lifted its position in shares of Tabula Rasa HealthCare by 79.8% in the third quarter. Wells Fargo & Company MN now owns 12,768 shares of the company’s stock worth $341,000 after buying an additional 5,668 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of Tabula Rasa HealthCare by 60.2% in the second quarter. California State Teachers Retirement System now owns 16,500 shares of the company’s stock worth $248,000 after buying an additional 6,200 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Tabula Rasa HealthCare by 47.2% in the second quarter. Bank of New York Mellon Corp now owns 19,412 shares of the company’s stock worth $293,000 after buying an additional 6,228 shares in the last quarter. Finally, New York State Common Retirement Fund lifted its position in shares of Tabula Rasa HealthCare by 257.0% in the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock worth $151,000 after buying an additional 7,199 shares in the last quarter. Institutional investors own 31.85% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2018/01/01/tabula-rasa-healthcare-inc-trhc-receives-average-recommendation-of-buy-from-brokerages.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Stock Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related stocks with our FREE daily email newsletter.